|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ramucirumab: successfully targeting angiogenesis in gastric cancer 显示文摘 | JAVLE M SMYTH EC CHAU I | 2014 | Clin Cancer Res2014，20，23： | 1 |
| 2 | Capecitabine in advanced gastric cancer显示文摘 | OkinesA Chau I Cunningham D | 2007 | ExpertOpin Pharmacother2007，8，16： | 1 |
| 3 | Adjuvant therapy in colon cancer -- what, when and how显示文摘 | Chau I Cunningham D | 2006 | Ann 0ncol2006，17，9： | 1 |
| 4 | Capecitabine in advanced gasgric cancer显示文摘 | Okines A Chau I Cunningham D | 2007 | Expert Opin Pharmacother2007，8，16： | 1 |
| 5 | The impact ofprimary tumour origins in patients with advancedoesophageal, oesophago-gastric junction and gastricadenocarcinoma-individual patient data from 1775patients in four randomised controlled trials 显示文摘 | Chau I、Norman AR Cunningham D | 2009 | AnnOncol2009，20，5： | 1 |
| 6 | Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan显示文摘 | Dawson G J Mushahwar I K Chau K H Gitnick G L | 1992 | Lancet1992，340，8816： | 1 |
| 7 | Insulin-like growth factor 1 receptor targeted therapeutics:novel compounds and novel treatment strategies for cancer medicine显示文摘 | HEWISH M CHAU I CUNNINGHAM D | 2009 | Recent内t Anticancer Drug Discov2009，4，1： | 1 |
| 8 | Capecitabine in advanced gastric cancer显示文摘 | OKINES A CHAU I CUNNUNGHAM D | 2007 | Expert Opin Pharmacother2007，8，16： | 1 |
| 9 | Phase Ⅲ randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer 显示文摘 | Cunningham D Chau I Stocken D D | 2009 | J Clin Oncol2009，27，33： | 1 |
| 10 | Extrafascial excision of the rectum: surgical anatomy of the fascia propria显示文摘 | BISSET I P CHAU K Y HILL G L | 2000 | Dis Colon Rec- tum2000，43，7： | 1 |
| 11 | Capecitabine in advanced gastric cancer显示文摘 | Okines A Chau I Cunningham D | 2007 | Expert Opin Pharmacother2007，8，16： | 1 |
| 12 | Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer 显示文摘 | Cunningham D Chau I Stocken DD | 2009 | J Clin Oncol2009，27，： | 1 |
| 13 | Capecitabine in advanced gastric cancer显示文摘 | Okines A Chau I Cunningham D | | 0，，16： | 1 |
| 14 | Gemcitabine,cisplatin(P)and methyprednisolone:A Salvage regimen in relapsed Hodgkin'sdisease and non-Hodgkin's lymphoma显示文摘 | Waters J Chau I Norman AR | 2004 | J Clin Oncol2004，22，： | 1 |
| 15 | Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives显示文摘 | Chau I Chan S Cunningham D | 2003 | Clin Colorectal Cancer2003，3，1： | 1 |
| 16 | Randomized, phase II study of bevacizumab with mFOLFOX6 or FOLFOXIRI in patients with initially unresectable liver metastases from eoloreetal cancer: Resect- ability and safety in OLIVIA 显示文摘 | Gruenberger T Bridgewater JA Chau I | 2013 | J Clinical Onco12013，，： | 1 |
| 17 | Epirubicin,oxali- platin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogas- tric cancer (REAL3) : a randomised, open-label phase 3 trial 显示文摘 | Waddell T Chau I Cunningham D | 2013 | Lancet Oncol2013，14，6： | 1 |
| 18 | A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRl显示文摘 | Chau I Joulain F Iqbal SU | 2014 | BMC Cancer2014，14，： | 1 |
| 19 | Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer 显示文摘 | Chau I Brown G Cunningham D | 2006 | J Clin Oncol2006，24，4： | 1 |
| 20 | Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3):a randomised, open-label phase 3 trial显示文摘 | Waddell T Chau I Cunningham D Gonzalez D Okines A F Okines C | 2013 | Lancet Oncol2013，14，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员